Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort.
Saved in:
| Title: | Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort. |
|---|---|
| Authors: | Rha, Sun Young1 (AUTHOR) rha7655@yuhs.ac, Castanon, Eduardo2 (AUTHOR), Gill, Sanjeev3 (AUTHOR), Senellart, Helene4 (AUTHOR), Lopez, Juanita5 (AUTHOR), Márquez‐Rodas, Iván6 (AUTHOR), Victoria, Iván7 (AUTHOR), Kim, Tae Min8 (AUTHOR), Lwin, Zarnie9 (AUTHOR), Burger, Michael C.10 (AUTHOR), Simonelli, Matteo11,12 (AUTHOR), Cassier, Philippe A.13 (AUTHOR), Hendifar, Andrew E.14 (AUTHOR), Ascierto, Paolo A.15 (AUTHOR), Dutcus, Corina16 (AUTHOR), Okpara, Chinyere E.17 (AUTHOR), Ghori, Razi18 (AUTHOR), Jin, Fan18 (AUTHOR), Groisberg, Roman18 (AUTHOR), Villanueva, Luis19 (AUTHOR) |
| Source: | Cancer (0008543X). Aug2025, Vol. 131 Issue 16, p1-12. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
